Načítá se...
Epigenetic Drugs for Multiple Sclerosis
There is increasing evidence that abnormalities in epigenetic mechanisms of gene expression contribute to the development of multiple sclerosis (MS). Advances in epigenetics have given rise to a new class of drugs, epigenetic drugs. Although many classes of epigenetic drugs are being investigated, a...
Uloženo v:
| Vydáno v: | Curr Neuropharmacol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Science Publishers
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4787283/ https://ncbi.nlm.nih.gov/pubmed/26813117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150211001600 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|